Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger

PLoS Pathogens

Volumn 12, Issue 1, 2016, Pages

  Markosyan, Ruben M ^a   Miao, Chunhui ^b   Zheng, Yi Min ^b   Melikyan, Gregory B ^c   Liu, Shan Lu ^b   Cohen, Fredric S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THERMOLYSIN; VIRUS GLYCOPROTEIN; CATHEPSIN; VIRUS FUSION PROTEIN;

ARTICLE; CELL FUSION; CONTROLLED STUDY; EBOLAVIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLUENZA VIRUS; PATCH CLAMP TECHNIQUE; PH; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; VIRUS INFECTION; ANIMAL; CHLOROCEBUS AETHIOPS; COS CELL LINE; EBOLA HEMORRHAGIC FEVER; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ENTRY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATHEPSINS; CERCOPITHECUS AETHIOPS; COS CELLS; EBOLAVIRUS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HEMORRHAGIC FEVER, EBOLA; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; PATCH-CLAMP TECHNIQUES; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION;

EID: 84956847160     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005373     Document Type: Article

References (67)

1. Feldmann H, Geisbert TW, (2011) Ebola haemorrhagic fever. Lancet 377: 849–862. doi: 10.1016/S0140-6736(10)60667-8 21084112
2. Choi WY, Hong KJ, Hong JE, Lee WJ, (2015) Progress of vaccine and drug development for Ebola preparedness. Clin Exp Vaccine Res 4: 11–16. doi: 10.7774/cevr.2015.4.1.11 25648233
3. Boulant S, Stanifer M, Kural C, Cureton DK, Massol R, et al. (2013) Similar uptake but different trafficking and escape routes of reovirus virions and infectious subvirion particles imaged in polarized Madin-Darby canine kidney cells. Mol Biol Cell 24: 1196–1207. doi: 10.1091/mbc.E12-12-0852 23427267
4. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X, (2003) Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100: 9280–9285. 12883000
5. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB, (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433–444. doi: 10.1016/j.cell.2009.02.046 19410541
6. Nour AM, Li Y, Wolenski J, Modis Y, (2013) Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses. PLoS Pathog 9: e1003585. doi: 10.1371/journal.ppat.1003585 24039574
7. Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, et al. (2012) Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J Virol 86: 364–372. doi: 10.1128/JVI.05708-11 22031933
8. Bar S, Takada A, Kawaoka Y, Alizon M, (2006) Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol 80: 2815–2822. 16501090
9. Dube D, Brecher MB, Delos SE, Rose SC, Park EW, et al. (2009) The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J Virol 83: 2883–2891. doi: 10.1128/JVI.01956-08 19144707
10. Takada A, Robison C, Goto H, Sanchez A, Murti KG, et al. (1997) A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94: 14764–14769. 9405687
11. Wool-Lewis RJ, Bates P, (1999) Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol 73: 1419–1426. 9882347
12. Bhattacharyya S, Hope TJ, Young JA, (2011) Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology 419: 1–9. doi: 10.1016/j.virol.2011.07.018 21855102
13. Brindley MA, Hughes L, Ruiz A, McCray PB, Jr.Sanchez A, et al. (2007) Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol 81: 7702–7709. 17475648
14. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340–343. doi: 10.1038/nature10348 21866103
15. Côté M, Misasi J, Ren T, Bruchez A, Lee K, et al. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344–348. doi: 10.1038/nature10380 21866101
16. Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, et al. (2010) Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J Virol 84: 2972–2982. doi: 10.1128/JVI.02151-09 20053739
17. Manicassamy B, Wang J, Jiang H, Rong L, (2005) Comprehensive analysis of ebola virus GP1 in viral entry. J Virol 79: 4793–4805. 15795265
18. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, et al. (2012) Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 31: 1947–1960. doi: 10.1038/emboj.2012.53 22395071
19. Wang J, Manicassamy B, Caffrey M, Rong L, (2011) Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry. Virol Sin 26: 156–170. doi: 10.1007/s12250-011-3194-9 21667336
20. Bale S, Liu T, Li S, Wang Y, Abelson D, et al. (2011) Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion. PLoS Negl Trop Dis 5: e1395. doi: 10.1371/journal.pntd.0001395 22102923
21. Cosset FL, Lavillette D, (2011) Cell entry of enveloped viruses. Adv Genet 73: 121–183. doi: 10.1016/B978-0-12-380860-8.00004-5 21310296
22. Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, et al. (1998) Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72: 6442–6447. 9658086
23. Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, et al. (2010) Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol 12: 148–157. doi: 10.1111/j.1462-5822.2009.01385.x 19775255
24. Kaletsky RL, Simmons G, Bates P, (2007) Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81: 13378–13384. 17928356
25. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, et al. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80: 4174–4178. 16571833
26. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM, (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308: 1643–1645. 15831716
27. Gregory SM, Harada E, Liang B, Delos SE, White JM, et al. (2011) Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc Natl Acad Sci U S A 108: 11211–11216. doi: 10.1073/pnas.1104760108 21690393
28. Markosyan RM, Melikyan GB, Cohen FS, (2001) Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation. Biophys J 80: 812–821. 11159448
29. Melikyan GB, Markosyan RM, Hemmati H, Delmedico MK, Lambert DM, et al. (2000) Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 151: 413–423. 11038187
30. Chernomordik LV, Frolov VA, Leikina E, Bronk P, Zimmerberg J, (1998) The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140: 1369–1382. 9508770
31. Melikyan GB, Brener SA, Ok DC, Cohen FS, (1997) Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol 136: 995–1005. 9060465
32. Zavorotinskaya T, Qian Z, Franks J, Albritton LM, (2004) A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol 78: 473–481. 14671127
33. Cote M, Zheng YM, Albritton LM, Liu SL, (2011) Single residues in the surface subunits of oncogenic sheep retrovirus envelopes distinguish receptor-mediated triggering for fusion at low pH and infection. Virology 421: 173–183. doi: 10.1016/j.virol.2011.09.022 22018783
34. Neufeld EB, Wastney M, Patel S, Suresh S, Cooney AM, et al. (1999) The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 274: 9627–9635. 10092649
35. Haines KM, Vande Burgt NH, Francica JR, Kaletsky RL, Bates P, (2012) Chinese hamster ovary cell lines selected for resistance to ebolavirus glycoprotein mediated infection are defective for NPC1 expression. Virology 432: 20–28. doi: 10.1016/j.virol.2012.05.018 22726751
36. Delos SE, La B, Gilmartin A, White JM, (2010) Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry. J Virol 84: 5687–5694. doi: 10.1128/JVI.02583-09 20335266
37. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, et al. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454: 177–182. doi: 10.1038/nature07082 18615077
38. Cote M, Zheng YM, Albritton LM, Liu SL, (2008) Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations. J Virol 82: 2543–2554. 18094165
39. Pak CC, Krumbiegel M, Blumenthal R, (1994) Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusion. J Gen Virol 75 (Pt 2): 395–399. 8113761
40. Turk B, Turk V, Turk D, (1997) Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 378: 141–150. 9165064
41. De Clercq E, (2015) Ebola virus (EBOV) infection: Therapeutic strategies. Biochem Pharmacol 93: 1–10. doi: 10.1016/j.bcp.2014.11.008 25481298
42. Wool-Lewis RJ, Bates P, (1998) Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72: 3155–3160. 9525641
43. Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, et al. (2015) Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347: 995–998. doi: 10.1126/science.1258758 25722412
44. Simmons JA, D'Souza R.S., Rua M., Galione A., Casanova J.E., White J.M., (2015) The Ebola virus Glycoprotein Directs Fusion Through NPC1+ Endolysosomes. J Virol.
45. Mingo RM, Simmons JA, Shoemaker CJ, Nelson EA, Schornberg KL, et al. (2015) Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol 89: 2931–2943. doi: 10.1128/JVI.03398-14 25552710
46. Ellens H, Bentz J, Mason D, Zhang F, White JM, (1990) Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry 29: 9697–9707. 2271610
47. Plonsky I, Zimmerberg J, (1996) The initial fusion pore induced by baculovirus GP64 is large and forms quickly. J Cell Biol 135: 1831–1839. 8991094
48. Pager CT, Craft WW, Jr.Patch J, Dutch RE, (2006) A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346: 251–257. 16460775
49. Pager CT, Dutch RE, (2005) Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. Journal of Virology 79: 12714–12720. 16188974
50. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, et al. (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 102: 11876–11881. 16081529
51. Diederich S, Moll M, Klenk HD, Maisner A, (2005) The nipah virus fusion protein is cleaved within the endosomal compartment. J Biol Chem 280: 29899–29903. 15961384
52. Pager CT, Wurth MA, Dutch RE, (2004) Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein. J Virol 78: 9154–9163. 15308711
53. Subbiah M, Khattar SK, Collins PL, Samal SK, (2011) Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens. J Virol 85: 5394–5405. doi: 10.1128/JVI.02696-10 21450835
54. Russell CJ, (2014) Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology. Curr Top Microbiol Immunol 385: 93–116. doi: 10.1007/82_2014_393 25007844
55. McGrath ME, (1999) The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct 28: 181–204. 10410800
56. Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D, (1999) Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem 264: 100–109. 10447678
57. Lockwood TD, (2002) Cathepsin B responsiveness to glutathione and lipoic acid redox. Antioxid Redox Signal 4: 681–691. 12230881
58. Pillay CS, Dennison C, (2002) Cathepsin B stability, but not activity, is affected in cysteine:cystine redox buffers. Biol Chem 383: 1199–1204. 12437106
59. White JM, Schornberg KL, (2012) A new player in the puzzle of filovirus entry. Nat Rev Microbiol 10: 317–322. doi: 10.1038/nrmicro2764 22491356
60. Rozhin J, Robinson D, Stevens MA, Lah TT, Honn KV, et al. (1987) Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res 47: 6620–6628. 2824039
61. Harrison JS, Higgins CD, Chandran K, Lai JR, (2011) Designed protein mimics of the Ebola virus glycoprotein GP2 alpha-helical bundle: stability and pH effects. Protein Sci 20: 1587–1596. doi: 10.1002/pro.688 21739501
62. Markosyan RM, Cohen FS, Melikyan GB, (2003) HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol Biol Cell 14: 926–938. 12631714
63. Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, et al. (2012) Structural basis for differential neutralization of ebolaviruses. Viruses 4: 447–470. doi: 10.3390/v4040447 22590681
64. Markosyan RM, Cohen FS, (2013) The transmembrane domain and acidic lipid flip-flop regulates voltage-dependent fusion mediated by class II and III viral proteins. PLoS One 8: e76174. doi: 10.1371/journal.pone.0076174 24124539
65. Samsonov AV, Chatterjee PK, Razinkov VI, Eng CH, Kielian M, et al. (2002) Effects of membrane potential and sphingolipid structures on fusion of Semliki Forest virus. J Virol 76: 12691–12702. 12438595
66. Côté M, Kucharski TJ, Liu S- L, (2008) Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection. J Virol 82: 9023–9034. doi: 10.1128/JVI.00648-08 18632865
67. Narayan S, Barnard RJ, Young JA, (2003) Two retroviral entry pathways distinguished by lipid raft association of the viral receptor and differences in viral infectivity. J Virol 77: 1977–1983. 12525631